Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10220222 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
We here present the first whole exome sequencing data and to our knowledge the largest CNA study in OGCT. We confirmed that earlier reported KIT mutations were frequent in dysgerminomas and mixed forms with a dysgerminoma component, whereas chromosome 12p gains were present in all histological subtypes except pure immature teratomas. We detected recurrent KRAS mutations, recurrent focal deletions and an enrichment in the PI3K/AKT/PTEN pathway in yolk sac tumors. Several of these aberrations involve targetable pathways, offering novel treatment modalities for OGCT.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Els Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, Sileny N. Han, Philippe Moerman, Michalis Liontos, Maria Papaspirou, Jolanta Kupryjanczyk, Claus Hogdall, Estrid Hogdall, Ana Oaknin, Angel Garcia, Sven Mahner, Fabian Trillsch, David Cibula,